Status:
UNKNOWN
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
Lead Sponsor:
Oklahoma State University Center for Health Sciences
Collaborating Sponsors:
Oklahoma State University
University of Oklahoma
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
Brief Summary
Diabetic retinopathy (DR), a complication of diabetes, is a leading cause of blindness among working-aged adults globally. In its early stages, DR is symptomless, and can only be detected by an annual...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- For diabetic patients with DR:
- With 250.xx diabetes and 362.0x DR ICD-9 codes
- All variables are complete within the observation window
- For diabetic patients without DR:
- With 250.xx diabetes ICD-9 codes
- Without 362.0x DR ICD-9 codes
- All variables are complete within the observation window
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03769948
Start Date
February 1 2022
End Date
July 1 2023
Last Update
September 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.